⦁ Yousef Mirzaei, Ali Hussein Mer, Bahia Fattah Maran, Leila Omidvar, Fatemeh Misamogooe, Zahra Amirkhani, Nafiseh Javaheri Haghighi, Nader Bagheri, Zahra Keshtkaran, Behzad Rezaei, Farshad Bargrizaneh, Saeed Jahandideh, Nesa Barpour, Hosein Shahsavarani, Ahmadreza Bazyari, Meghdad Abdollahpour-Alitappeh*. Clinical and preclinical advances in PSMA-Directed Antibody-Drug conjugates (ADCs): Current status and hope for the future. Bioorganic Chemistry. 2024. DOI: 10.1016/j.bioorg.2024.107803.

⦁ Mohammad Javad Khosravanian, Yousef Mirzaei, Ali Hussein Mer, Maryam Keyhani-Khankahdani, Fatemeh Sarina Abdinia, Fatemeh Misamogooe, Zahra Amirkhani, Nader Bagheri, Anna Meyfour, Saeed Jahandideh, Nesa Barpour, Yousef Nikmanesh, Hosein Shahsavarani, Meghdad Abdollahpour-Alitappeh*. Nectin-4-directed antibody-drug conjugates (ADCs): Spotlight on preclinical and clinical evidence. Life Sciences. 2024. DOI: 10.1016/j.lfs.2024.122910.

⦁ Ali Hussein Mer, Yousef Mirzaei, Fatemeh Misamogooe, Nader Bagheri, Ahmadreza Bazyari, Zahra Keshtkaran, Anna Meyfour, Alireza Shahedi, Zahra Amirkhani, Ameneh Jafari, Nesa Barpour, Saeed Jahandideh, Behzad Rezaei, Yousef Nikmanesh, Meghdad Abdollahpour-Alitappeh*. Progress of antibody–drug conjugates (ADCs) targeting c-Met in cancer therapy; insights from clinical and preclinical studies. Drug Delivery and Translational Research. 2024. DOI: 10.1007/s13346-024-01564-3.

⦁ Zohreh Najminejad, Fatemeh Dehghani, Yousef Mirzaei, Ali Hussein Mer, Seyyed Amirreza Saghi, Mohadeseh Haji Abdolvahab, Nader Bagheri, Anna Meyfour, Ameneh Jafari, Saeed Jahandideh, Tohid Gharibi, Zahra Amirkhani, Hamed Delam, Noushin Mashatan, Hosein Shahsavarani, Meghdad Abdollahpour-Alitappeh*. Clinical Perspective: Antibody-Drug Conjugates (ADCs) for the Treatment of HER2-Positive Breast Cancer. Molecular Therapy. 2023. DOI: 10.1016/j.ymthe.2023.03.019.

⦁ Gharibi T, Hosseini A, Marofi F, Oraei M, Jahandideh S, Abdollahpour-Alitappeh M, Hashemi V, Motallebnezhad M, Babaloo Z, Baradaran B. Corrigendum to” IL-21 and IL-21-producing T cells are involved in multiple sclerosis severity and progression”[Immunol. Lett. 216 (2019) 12-20]. Immunology letters. 2021, 232, pp. 67. DOI: ⦁ 10.1016/j.imlet.2020.12.013.

⦁ Gharibi T, Hosseini A, Marofi F, Oraei M, Jahandideh S, Abdollahpour-Alitappeh M, Hashemi V, Motallebnezhad M, Babaloo Z, Baradaran B. IL-21 and IL-21-producing T cells are involved in multiple sclerosis severity and progression. Immunology letters. 2019, 216, pp. 12–20. DOI: ⦁ 10.1016/j.imlet.2019.09.003.

⦁ Abdollahpour-Alitappeh M, Lotfinia M, Razavi-Vakhshourpour S, Jahandideh S, Najminejad H, Sepehr KS, Moazami R, Shams E, Habibi-Anbouhi M, Abolhassani M. Evaluation of factors influencing antibody reduction for development of antibody drug conjugates. Iranian biomedical journal. 2017, 21(4), pp. 270–274. DOI: ⦁ 10.18869/acadpub.ibj.21.4.270.

⦁ Abdollahpour-Alitappeh M, Amanzadeh A, Heidarnejad F, Habibi-Anbouhi M, Lotfinia M, Razavi-Vakhshourpour S, Jahandideh S, Najminejad H, Balalaie S, Abolhassani M. Monomethyl auristatin E, a potent cytotoxic payload for development of antibody-drug conjugates against breast cancer. Novelty in Biomedicine. 2017, 5(3), pp. 98-103. DOI: 10.22037/nbm.v5i3.15523.

⦁ Abdollahpour-Alitappeh M, Razavi-vakhshourpour S, Lotfinia M, Jahandideh S, Najminejad H, Balalaie S, Moazzami R, Shams E, Habibi-Anbouhi M, Abolhassani M. Monomethyl auristatin E Exhibits Potent Cytotoxic Activity against Human Cancer Cell Lines SKBR3 and HEK293. Novelty in Biomedicine. 2017, 5(4), pp. 145-51. DOI: 10.22037/nbm.v5i4.15221.

Saeed Jahandideh, ⦁ Shohreh Khatami, ⦁ Ali Eslami Far, ⦁ Mehdi Kadivar. Anti-inflammatory effects of human embryonic stem cell-derived mesenchymal stem cells secretome preconditioned with diazoxide, trimetazidine and MG-132 on LPS-induced systemic inflammation mouse model. Artificial Cells, Nanomedicine, and Biotechnologyol. 2018;46(sup2):1178-1187.  DOI: 10.1080/21691401.2018.1481862.

⦁ Nastaran Mohammadi Ghahhari, Faezeh Maghsood, Saeed Jahandideh, Majid Lotfinia, Shirin Lak, Behrooz Johari, Asaad Azarnezhad, Mehdi Kadivar. Secretome of Aggregated Embryonic Stem Cell-Derived Mesenchymal Stem Cell Modulates the Release of Inflammatory Factors in Lipopolysaccharide-Induced Peripheral Blood Mononuclear Cells. Iran Biomed J. 2018 Jul;22(4):237-45. DOI: 10.22034/ibj.22.4.237

⦁ Saeed Jahandideh, Faezeh Maghsood, Nastaran Mohammadi Ghahhari, Majid Lotfinia, Mohammad Mohammadi, Behrooz Johari, Mehdi Kadivar. The effect of Trimetazidine and Diazoxide on immunomodulatory activity of human embryonic stem cell-derived mesenchymal stem cell secretome. Tissue Cell. 2017 Oct;49(5):597-602. DOI: 10.1016/j.tice.2017.08.003.
⦁ Omidvar L., Mer A.H., Mirzaei Y., Jahandideh S. et al. CD20-directed antibodydrug conjugates in non-hodgkin lymphoma: translating preclinical promise into clinical reality. J Hematol Oncol (2026). https://doi.org/10.1186/ s13045-026-01807-5